Evolutionary insights into sequence modifications governing chitin recognition and chitinase inactivity in YKL-40 (HC-gp39, CHI3L1)

被引:4
|
作者
Suzuki, Keita [1 ]
Okawa, Kazuaki [1 ]
Ohkura, Masashi [1 ]
Kanaizumi, Tomoki [1 ]
Kobayashi, Takaki [1 ]
Takahashi, Koro [1 ]
Takei, Hiromu [1 ]
Otsuka, Momo [1 ]
Tabata, Eri [1 ,2 ]
Bauer, Peter O. [3 ]
Oyama, Fumitaka [1 ]
机构
[1] Kogakuin Univ, Dept Chem & Life Sci, Hachioji, Tokyo, Japan
[2] Japan Soc Promot Sci PD, Chiyoda Ku, Tokyo, Japan
[3] Bioinova A s, Prague, Czech Republic
基金
日本学术振兴会;
关键词
HUMAN CARTILAGE GLYCOPROTEIN; SERUM YKL-40; CHITOOLIGOSACCHARIDE-BINDING; HUMAN CHITOTRIOSIDASE; RHEUMATOID-ARTHRITIS; CRYSTAL-STRUCTURE; TISSUE RESPONSES; POTENTIAL MARKER; PROTEIN; IDENTIFICATION;
D O I
10.1016/j.jbc.2024.107365
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
YKL-40, also known as human cartilage glycoprotein-39 (HC-gp39) or CHI3L1, shares structural similarities with chitotriosidase (CHIT1), an active chitinase, but lacks chitinase activity. Despite being a biomarker for inflammatory disorders and cancer, the reasons for YKL-40's inert chitinase function have remained elusive. This study reveals that the loss of chitinase activity in YKL-40 has risen from multiple sequence modifications influencing its chitin affinity. Contrary to the common belief associating the lack of chitinase activity with amino acid substitutions in the catalytic motif, attempts to activate YKL-40 by creating two amino acid mutations in the catalytic motif (MT-YKL-40) proved ineffective. Subsequent exploration that included creating chimeras of MT-YKL-40 and CHIT1 catalytic domains (CatDs) identified key exons responsible for YKL-40 inactivation. Introducing YKL-40 exons 3, 6, or 8 into CHIT1 CatD resulted in chitinase inactivation. Conversely, incorporating CHIT1 exons 3, 6, and 8 into MTYKL-40 led to its activation. Our recombinant proteins exhibited properly formed disulfide bonds, affirming a defined structure in active molecules. Biochemical and evolutionary analysis indicated that the reduced chitinase activity of MTYKL-40 correlates with specific amino acids in exon 3. M61I and T69W substitutions in CHIT1 CatD diminished chitinase activity and increased chitin binding. Conversely, substituting I61 with M and W69 with T in MT-YKL-40 triggered chitinase activity while reducing the chitin-binding activity. Thus, W69 plays a crucial role in a unique subsite within YKL-40. These fi ndings emphasize that YKL-40, though retaining the structural framework of a mammalian chitinase, has evolved to recognize chitin while surrendering chitinase activity.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Association of Circulating YKL-40 Levels and CHI3L1 Variants with the Risk of Spinal Deformity Progression in Adolescent Idiopathic Scoliosis
    Nada, Dina
    Julien, Cedric
    Rompre, Pierre H.
    Akoume, Marie-Yvonne
    Gorman, Kristen F.
    Samuels, Mark E.
    Levy, Emile
    Kost, Jason
    Li, Dawei
    Moreau, Alain
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [32] YKL-40 as a clinical biomarker in adult patients with CF: Implications of a CHI3L1 single nucleotide polymorphism in disease severity
    Coriati, Adele
    Bouvet, Guillaume F.
    Masse, Chantal
    Ducruet, Thierry
    Berthiaume, Yves
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (06) : E93 - E99
  • [33] Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and Prediction of Fatal and Non-fatal Ischemic Stroke
    Rathcke, Camilla Noelle
    Thomsen, Stine Brinkloev
    Linneberg, Allan
    Vestergaard, Henrik
    PLOS ONE, 2012, 7 (08):
  • [34] Association of Circulating YKL-40 Levels and CHI3L1 Variants with the Risk of Spinal Deformity Progression in Adolescent Idiopathic Scoliosis
    Dina Nada
    Cédric Julien
    Pierre H. Rompré
    Marie-Yvonne Akoume
    Kristen F. Gorman
    Mark E. Samuels
    Emile Levy
    Jason Kost
    Dawei Li
    Alain Moreau
    Scientific Reports, 9
  • [35] Intracellular Accumulation and Secretion of YKL-40 (CHI3L1) in the Course of DMSO-Induced HL-60 Cell Differentiation
    Jatczak-Pawlik, Izabela
    Ewiak-Paszynska, Alicja
    Domowicz, Malgorzata
    Jurewicz, Anna
    Stasiolek, Mariusz
    PHARMACEUTICALS, 2024, 17 (04)
  • [36] Chi3l1/YKL-40 is a Modulator of Glial Activation and Amyloid Plaque Deposition in Alzheimer Disease Which is Controlled by the Circadian Clock
    Lananna, Brian S.
    Del-Aguila, Jorge
    Farias, Fabiana
    Nadarajah, Collin S.
    Cruchaga, Carlos
    Musiek, Erik S.
    ANNALS OF NEUROLOGY, 2019, 86 : S121 - S121
  • [37] A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection
    Berres, Marie-Luise
    Papen, Sven
    Pauels, Katrin
    Schmitz, Petra
    Zaldivar, Mirko Moreno
    Hellerbrand, Claus
    Mueller, Tobias
    Berg, Thomas
    Weiskirchen, Ralf
    Trautwein, Christian
    Wasmuth, Hermann E.
    JOURNAL OF HEPATOLOGY, 2009, 50 (02) : 370 - 376
  • [38] Astrocyte-specific knockout of YKL-40/Chi3l1 reduces Aβ burden and restores memory functions in 5xFAD mice
    Zeng, Xiaoyan
    Cheung, Stanley K. K.
    Shi, Mengqi
    Or, Penelope M. Y.
    Li, Zhining
    Liu, Julia Y. H.
    Ho, Wayne L. H.
    Liu, Tian
    Lu, Kun
    Rudd, John A.
    Wang, Yubing
    Chan, Andrew M.
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [39] Astrocyte-specific knockout of YKL-40/Chi3l1 reduces Aβ burden and restores memory functions in 5xFAD mice
    Xiaoyan Zeng
    Stanley K. K. Cheung
    Mengqi Shi
    Penelope M. Y. Or
    Zhining Li
    Julia Y. H. Liu
    Wayne L. H. Ho
    Tian Liu
    Kun Lu
    John A. Rudd
    Yubing Wang
    Andrew M. Chan
    Journal of Neuroinflammation, 20
  • [40] Genetic variants in CHI3L1 influencing YKL-40 levels: Resequencing 900 individuals and genotyping 9000 individuals from the general population
    Kjaergaard, A. D.
    Johansen, J. S.
    Nordestgaard, B. G.
    Bojesen, S. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S122 - S123